ARTICLE | Company News
Biovail, Valeant Pharmaceuticals deal
October 4, 2010 7:00 AM UTC
The companies completed their previously announced merger in which Valeant shareholders received $3.3 billion in cash and Biovail stock. The newco, Valeant Pharmaceuticals International Inc., will tra...